Does AMPYRA Cause Multiple sclerosis relapse? 159 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Multiple sclerosis relapse have been filed in association with AMPYRA. This represents 4.0% of all adverse event reports for AMPYRA.
159
Reports of Multiple sclerosis relapse with AMPYRA
4.0%
of all AMPYRA reports
3
Deaths
49
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From AMPYRA?
Of the 159 reports, 3 (1.9%) resulted in death, 49 (30.8%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPYRA. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does AMPYRA Cause?
Drug ineffective (711)
Gait disturbance (518)
Dizziness (354)
Insomnia (313)
Balance disorder (262)
Headache (247)
Nausea (233)
Fall (208)
Fatigue (185)
Asthenia (179)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which AMPYRA Alternatives Have Lower Multiple sclerosis relapse Risk?
AMPYRA vs AMRUBICIN
AMPYRA vs AMSACRINE
AMPYRA vs ANAGRELIDE
AMPYRA vs ANAKINRA
AMPYRA vs ANAMORELIN